Pipeline Bioresearch ApS (under frivillig likvidation)Active

CVR 37831735

Key figures

0 kr.-100,0%
Revenue 2022
02 m4 m6 m2017201820192022

Key ratios

2023
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
02 m4 m2017201820192020202120222023
Financial statements2017–2023
2017201820192020202120222023
Balance sheet — assets
Cash and cash equivalents133.552225.379169.038361.219492.666341.074256.458
Total current assets1.776.0302.872.2682.521.3322.247.485552.021341.074256.477
Total non-current assets282.123265.699258.220246.5760——
Total assets2.058.1533.137.9672.779.5522.494.061552.021341.074256.477
Balance sheet — liabilities and equity
Current liabilities1.535.1612.619.6682.278.7401.972.60528.58552.747138.688
Non-current liabilities———————
Total liabilities1.535.1612.619.6682.278.7401.972.60528.58552.747138.688
Share capital50.00050.00050.00050.00050.00050.00050.000
Retained earnings of previous periods472.992468.299450.812471.456473.436238.32767.789
Profit for the year34.584-4.692-17.48726.0451.971-235.110-170.538
Total equity522.992518.299500.812521.456523.436288.327117.789
Income statement
Sales revenue3.494.6674.202.3212.022.642——0—
Gross profit———1.612.3371.430.000—-67.097
Operating profit47.237-2.303-13.62130.2206.051-231.222—
EBITDA67.58814.121-6.14241.86417.196——
Profit before income tax44.339-4.692-17.48727.1352.527-235.110—
Profit for the reporting year34.584-4.692-17.48726.0451.971-235.110-170.538
Labour costs1.945.3381.822.4312.028.7841.570.4731.412.804—62.000
Depreciation of non-current assets20.35116.4247.47911.64411.145——
Other indicators
Employees——————1

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

About the company

Annual report 2023

Selskabets aktiviteter har tidligere bestået i at eje aktier og anparter i andre selskaber samt enhver beslægtet aktivitet efter direktionens skøn og nærmere beslutning. Væsentlige ændringer i selskabets aktiviteter Selskabet er under solvent likvidation og forventes lukket i løbet af 2024

Resultatopgørelsen for tiden 01.01.23 - 31.12.23 udviser et resultat på DKK -170.538 mod DKK -235.110 for tiden 01.01.22 - 31.12.22. Balancen viser en egenkapital på DKK 117.789.

Excerpt from the management's review in the latest annual report.

Pipeline Bioresearch ApS (under frivillig likvidation) — cvrprofil.dk